Form 4 for ACH ACCENDRA HEALTH INC/VA/
Accepted 2022-05-11 00:00:00 ET · period of report 2022-05-10 · accession 0001062993-22-012099 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-05-11 | 2022-05-10 | ACH | Starck Daniel J | EVP, Pres Patient Direct, CEO of Apria | A - Grant | $0.00 | +21.6K | 21.6K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-05-10 | A | A | 21,598 | $0.00 | 21,598 | D | — | — | (F1) Restricted stock grant which vests one-third per year over three years. |